Researchers collected admission and discharge nasal swabs from patients, totaling more than 27,000 specimens, using three different commercial real-time polymerase chain reaction MRSA tests. The researchers found the performance of the three commercial tests were fairly similar.
Given the similar performance of all three tests, the researchers suggest healthcare providers consider the cost of the MRSA tests as well as the specificity of the test’s results to determine which would be best for the hospital’s specific surveillance program.
More articles on MRSA:
Tapeworm drug effectively treats MRSA in lab study
Former NFL player sues team over MRSA infection
Cigarette smoke makes MRSA more aggressive, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
